Report #2841180

Received May 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 17 yrs
State: MA
Recovered: Unknown
Vaccinated: Apr 7, 2025
Onset: Apr 7, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	UNK	553j7	—

Symptoms (1)

Expired product administered

Symptom narrative

patient received Engerix-B on 7-APR-2025 and later it was realized that it expired 28-MAR-2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received HBV (Engerix B pediatric) (batch number 553j7, expiry date 28-MAR-2025) for prophylaxis. On 07-APR-2025, the patient received Engerix B pediatric. On 07-APR-2025, an unknown time after receiving Engerix B pediatric, the patient experienced expired vaccine used (Verbatim: patient received Engerix-B on 7-APR-2025 and later it was realized that it expired 28-MAR-2025). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date :05-MAY-2025 Pharmacist reported that a 17-year-old patient received Engerix-B on 7-APR-2025 and later it was realized that it expired 28-MAR-2025, which led to Expired vaccine used. The reporter Consented to follow up.